Three solar panel manufacturers have asked U.S. authorities to investigate solar cell imports from South Korea, alleging that companies such as Hanwha’s Qcells are using those imports to circumvent tariffs imposed on Chinese products, according to a petition reviewed by Reuters.
The petition, submitted to the U.S. Department of Commerce on June 18, was filed on behalf of a manufacturing joint venture involving Canadian Solar, SEG, and Heliene, all of which operate solar panel production facilities in the United States.
AMER Calls for Fair Competition
The group, calling itself American Manufacturers for Energy Resilience (AMER), is seeking an anti-circumvention probe, accusing Qcells of shifting cell production to South Korea from China to avoid U.S. tariffs. Cells are the building blocks of modules, or panels, that convert sunlight into electricity.
Under U.S. trade law, tariffs can be extended to goods routed through third countries when processing there is minor.
An attorney for the group said it was seeking fairness.
“It is time that companies like Hanwha Qcells, that have been allowed to game both sides of U.S. trade law for far too long, are held accountable,” attorney John Anwesen said.
“The AMER coalition is focused on leveling the playing field to allow fair competition across American solar manufacturers, and this circumvention inquiry request is a step towards that goal,” Anwesen said in a statement.
Qcells Rejects Allegations
Qcells has two solar factories in the U.S. state of Georgia and has a goal to manufacture all the key components that go into a silicon-based solar panel on U.S. soil.
Qcells, which has invested billions into its U.S. manufacturing operations, has been a driving force behind recent U.S. trade petitions targeting solar imports from countries in Southeast Asia. Some of those imports supplied factories owned by Canadian Solar, SEG and Heliene.
“Qcells has led the effort to reshore solar manufacturing in the United States, and we have a decade-long record of supporting strong trade enforcement, not evading it,” Qcells spokesperson Marta Stoepker said in an emailed statement.
“We’ve reviewed this filing and are confident the evidence will show its claims are without merit.”
(With inputs from Reuters)
